Skip to main content
Equibles

Daphne Quimi

Chief Accounting Officer

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Daphne Quimi

Daphne Quimi was last confirmed as Board Member at Century Therapeutics, Inc. (IPSC) in a filing dated April 22, 2025. Daphne Quimi was last confirmed as Board Member at Amylyx Pharmaceuticals, Inc. (AMLX) in a filing dated April 24, 2024. Century Therapeutics, Inc. reported in an 8-K filed October 3, 2022 that Daphne Quimi was appointed Class I Director, effective October 1, 2022. Daphne Quimi has spoken on 13 earnings calls across 1 company, most recently on August 8, 2023.

“(i) Ms. Daphne Quimi to serve as a Class I director of the Company and as a member of the Audit Committee and Nominating and Corporate Governance Committee”
Century Therapeutics, Inc. Form 8-K, filed October 3, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Organization not stated

    Chief Accounting Officer

    SEC 8-K

    Current

    2021-09-29–present

  • Century Therapeutics, Inc. (IPSC)

    Board Member

    Proxy statement

    2022-01-01–2025-04-22

    Last confirmed by a filing; no departure on record

  • Amylyx Pharmaceuticals, Inc. (AMLX)

    Board Member

    Proxy statement

    2021-01-01–2024-04-24

    Last confirmed by a filing; no departure on record

  • Organization not stated

    CFO

    Proxy statement

    Start not stated–2024-04-24

    Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Company

Current role

Chief Accounting Officer

2021-09-29–present

13 appearances Latest appearance 2023-08-08

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q2 FY2023 Earnings Call

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q1 FY2023 Earnings Call

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q4 FY2022 Earnings Call

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q3 FY2022 Earnings Call

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q2 FY2022 Earnings Call

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q1 FY2022 Earnings Call

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q4 FY2021 Earnings Call

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q3 FY2021 Earnings Call

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q2 FY2021 Earnings Call

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q4 FY2020 Earnings Call

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q3 FY2020 Earnings Call

Show 2 earlier activities
  • Earnings call

    AMICUS THERAPEUTICS, INC. Q2 FY2020 Earnings Call

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q1 FY2020 Earnings Call